Profil
Mark Levick served as Global Head-Development at Sandoz Biopharmaceuticals from 2016 to 2019.
Dr. Levick was Chief Executive Officer at Alvotech from 2019 to 2023.
Dr. Levick was Chief Executive Officer & Director at InterAx Biotech AG from 2023 to 2025.
Dr. Levick was Chief Executive Officer at Alvotech hf.
Dr. Levick was Global Head at Novartis AG.
Dr. Levick earned a doctorate from the University of Cambridge and completed undergraduate studies at The University of Newcastle.
Ehemalige bekannte Positionen von Mark Levick
| Unternehmen | Position | Ende |
|---|---|---|
InterAx Biotech AG
InterAx Biotech AG Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops a platform for discovery of functionally selective drugs | Vorstandsvorsitzender | 17.10.2025 |
| ALVOTECH | Vorstandsvorsitzender | 01.01.2023 |
Sandoz Biopharmaceuticals | Corporate Officer/Principal | 01.01.2019 |
| NOVARTIS AG | Corporate Officer/Principal | 01.07.2016 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Vorstandsvorsitzender | - |
Ausbildung von Mark Levick
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Newcastle
The University of Newcastle Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
InterAx Biotech AG
InterAx Biotech AG Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops a platform for discovery of functionally selective drugs | Commercial Services |
Alvotech
Alvotech BiotechnologyHealth Technology Develops biologic medicines | Health Technology |
Sandoz Biopharmaceuticals |
















